(Q38814798)

6 September 2017

title

Telomerase inhibitors: a patent review (2010-2015). (English)

1 reference

6 September 2017

Ruo-Jun Man

1

1 reference

6 September 2017

Long-Wang Chen

series ordinal

2

1 reference

6 September 2017

Hai-Liang Zhu

series ordinal

3

1 reference

6 September 2017

language of work or name

English

0 references

publication date

22 April 2016

1 reference

Expert Opinion on Therapeutic Patents

6 September 2017

published in

1 reference

6 September 2017

volume

26

1 reference

6 September 2017

issue

6

1 reference

6 September 2017

page(s)

679-688

1 reference

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

The burden of non communicable diseases in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

21 January 2018

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

21 January 2018

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

21 January 2018

Targeted cancer therapy

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

The epidermal growth factor receptor pathway: a model for targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Targeting targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Hayflick, his limit, and cellular ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

The telomere hypothesis of cellular aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

The illusion of cell immortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

A survey of telomerase activity in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Telomeres and telomerase in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Telomeres, telomerase and senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Quantitative visualization of DNA G-quadruplex structures in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

T-loop assembly in vitro involves binding of TRF2 near the 3' telomeric overhang

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Specific Association of Human Telomerase Activity with Immortal Cells and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Telomerase and cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Telomerase, Cell Immortality, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Telomeres and telomerase: their mechanisms of action and the effects of altering their functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Telomerase inhibition in cancer therapeutics: molecular-based approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

The RNA component of human telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Telomerase catalytic subunit homologs from fission yeast and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Human telomerase contains evolutionarily conserved catalytic and structural subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Reverse transcriptase motifs in the catalytic subunit of telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Comparative biology of mammalian telomeres: hypotheses on ancestral states and the roles of telomeres in longevity determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Mechanisms and regulation of DNA end resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Telomere length regulation: coupling DNA end processing to feedback regulation of telomerase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Replication and protection of telomeres

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Telomere loss as a mechanism for chromosome instability in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Heterogeneity in telomere length of human chromosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Telomeres in cancer and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Telomerase reverse transcriptase related with telomerase activity regulates tumorigenic potential of mouse embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Clinical implications of telomerase in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

WRN loss induces switching of telomerase-independent mechanisms of telomere elongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Inhibition of telomerase induces alternative lengthening of telomeres during human esophageal carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Depletion of Ku70/80 reduces the levels of extrachromosomal telomeric circles and inhibits proliferation of ALT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Telomerase inhibition and telomere targeting in hematopoietic cancer cell lines with small non-nucleosidic synthetic compounds (BIBR1532).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Targeting telomerase for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Functional conservation of the telomerase protein Est1p in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

A sensitive fluorescence strategy for telomerase detection in cancer cells based on T7 exonuclease-assisted target recycling amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Analysis of telomerase by the telomeric hemin/G-quadruplex-controlled aggregation of au nanoparticles in the presence of cysteine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

State-of-the-art methodologies for the discovery and characterization of DNA G-quadruplex binders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

The evolving role of telomerase inhibitors in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Oligonucleotide inhibitors of telomerase: prospects for anticancer therapy and diagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Telomerase: a target for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

Targeting telomeres and telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13543776.2016.1181172

10.1080/13543776.2016.1181172

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference